Intradermal Hepatitis-B-vaccination in non-responders after application of imiquimod 5% at the site of vaccination

Authors
Category Primary study
Registry of TrialsNetherlands Trial Register
Year 2007
INTERVENTION: Intradermal hepatitis B vaccination with recombinant vaccine after topical treatment with imiquimod 5% cream CONDITION: ; non‐responsiveness to hepatitis B vaccination ; ; PRIMARY OUTCOME: Serologic response after vaccination SECONDARY OUTCOME: Adverse events ; Cellular immunity INCLUSION CRITERIA: 1. >18 yrs; 2. Minimal 2 series of Hepatitis B vaccination (= minimal 6 intramuscular injections of 10microgr recombinant hepatitis B vaccine) with antibody titre <10IU/ml.
Epistemonikos ID: ff137cd73fff41d9556729285a34ade9a6a5dfe1
First added on: Aug 21, 2024